Coronary Stents Market to Reach US$ 12,846.6 Mn by 2035, Driven by Rising Cardiovascular Disease Burden and Advances in Stent Technology

The global coronary stents market is witnessing steady expansion as healthcare systems respond to the growing burden of cardiovascular diseases and increasing demand for effective, minimally invasive interventions. The industry was valued at US$ 7,222.5 Mn in 2024 and is expected to grow at a CAGR of 5.3% between 2025 and 2035, crossing US$ 12,846.6 Mn by 2035.

Coronary stents are small tube-like medical devices implanted in narrowed or blocked coronary arteries to restore and maintain blood flow to the heart. They are commonly used during percutaneous coronary intervention (PCI), typically following balloon angioplasty. By providing structural support to the artery, stents help maintain vessel patency after the blockage has been treated.

The market is increasingly characterized by technological progress, particularly in drug-eluting stents (DES), advanced metallic alloys, bioresorbable technologies, and sophisticated drug-delivery mechanisms.

Discover what the latest data reveals in our Report sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23

Market Overview

Coronary artery disease develops when plaque accumulates in the arteries supplying blood to the heart, potentially restricting oxygen-rich blood flow. Coronary stenting has become an established intervention for appropriately selected patients with obstructive coronary disease.

The two major conventional categories are bare-metal stents (BMS) and drug-eluting stents (DES). While BMS primarily provide mechanical support, DES incorporate drug coatings designed to reduce neointimal growth and the risk of restenosis. Bioabsorbable vascular scaffolds (BVS) represent another area of technological development, with research focused on temporary vessel support followed by gradual resorption.

Advances in cobalt-chromium and other high-performance materials have also contributed to improved stent strength, flexibility, deliverability, and biocompatibility.

Key Drivers of Market Growth

Increasing Demand for Minimally Invasive Procedures

The growing preference for minimally invasive cardiovascular procedures is a major factor supporting market development. PCI and coronary stenting can provide an alternative to more invasive surgical approaches for appropriate patients, potentially reducing hospital stays, procedural trauma, and recovery time.

As patients and healthcare professionals increasingly emphasize faster recovery and patient-centered treatment, demand for minimally invasive cardiovascular interventions continues to support coronary stent adoption. Improvements in stent design, delivery systems, and drug technologies are further strengthening the clinical utility of these procedures.

Favorable Reimbursement Policies

Reimbursement frameworks covering coronary interventions also play an important role in improving access to cardiovascular treatment. In markets where PCI and coronary stent procedures receive reimbursement support, patients may face lower direct treatment costs, encouraging timely intervention.

The increasing focus on value-based healthcare is also influencing device development. Healthcare providers and payers are placing greater emphasis on clinical outcomes, safety, and long-term healthcare costs, encouraging manufacturers to develop technologies designed to improve procedural and patient outcomes.

Emerging Trends

Drug-eluting stents remain a major technology segment because of their drug-delivery capabilities and role in reducing restenosis. Advances in polymer coatings, therapeutic agents, and delivery mechanisms are enabling manufacturers to improve stent performance.

Another important trend is the development of next-generation metallic stents using materials such as cobalt-chromium. These materials can provide a balance of radial strength and flexibility while enabling thinner stent platforms.

Research into bioresorbable vascular technologies is also creating opportunities for innovation. These technologies are designed to provide temporary vessel support while potentially reducing the long-term presence of a permanent implant.

New Opportunities and Challenges

The increasing prevalence of cardiovascular disease across aging populations creates opportunities for coronary stent manufacturers. Growing healthcare expenditure, improvements in catheterization laboratory infrastructure, and expansion of specialized cardiac centers in emerging economies can further broaden market opportunities.

Asia Pacific, Latin America, and other developing healthcare markets offer opportunities as access to advanced cardiovascular procedures expands. Local manufacturing capabilities and increasing investment in medical technology may also support market development.

However, the industry faces challenges related to stringent regulatory requirements, product safety, clinical validation, pricing pressures, and competition among medical-device manufacturers. Regulatory approval for new stent technologies can require extensive clinical evidence, increasing development costs and timelines.

Regional Insight

North America is expected to account for a major share of the global coronary stents market during the forecast period. The region benefits from advanced healthcare infrastructure, established cardiac care facilities, significant investment in medical research, and widespread access to sophisticated interventional cardiology procedures.

The prevalence of cardiovascular disease, along with demand for advanced treatment options, supports the adoption of drug-eluting stents and other innovative technologies. The presence of major medical-device companies and a strong regulatory and clinical research ecosystem further contributes to regional market development.

Europe is another important market, supported by established healthcare systems and continued adoption of advanced cardiovascular technologies. Meanwhile, Asia Pacific is expected to offer substantial growth opportunities as healthcare infrastructure improves, cardiovascular disease awareness increases, and access to interventional procedures expands.

Buy this Premium Research Report for exclusive, in-depth insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=23<ype=S

Competitive Landscape

The coronary stents industry is characterized by ongoing product development, regulatory approvals, clinical studies, strategic partnerships, and expansion of product portfolios. Companies are investing in technologies designed to improve stent deliverability, flexibility, drug release, biocompatibility, and long-term clinical performance.

Prominent participants include Abbott Laboratories, AlviMedica, B. Braun Melsungen AG, Biosensors International Group, Ltd., Shandong JW Medical Systems LTD., Boston Scientific Corporation, Cook Medical Inc., Elixir Medical Corp., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Eurocor GmbH, OrbusNeich Medical Company Limited, Shanghai MicroPort Medical Co., Ltd., Sino Medical Sciences Technology Inc., Terumo Corporation, Meril Life Sciences Pvt. Ltd., and Balton.

Future Outlook

The coronary stents market is expected to maintain steady growth through 2035 as cardiovascular disease remains a significant healthcare concern and minimally invasive treatment continues to evolve. Future development is likely to center on thinner stent platforms, improved drug-delivery systems, advanced materials, bioresorbable technologies, and enhanced delivery mechanisms.

Manufacturers are also expected to focus on clinical evidence, regulatory approvals, cost efficiency, and product differentiation. As healthcare providers increasingly emphasize patient outcomes and procedural efficiency, innovation in coronary stent technology is likely to remain central to competitive strategies.

With the market projected to increase from US$ 7,222.5 Mn in 2024 to US$ 12,846.6 Mn by 2035, the industry presents continued opportunities for medical-device companies, healthcare providers, and technology developers involved in interventional cardiology.

Important FAQs with Answers

1. How big was the global coronary stents market in 2024?

The global coronary stents market was valued at US$ 7,222.5 Mn in 2024.

2. How big will the coronary stents market be in 2035?

The market is projected to surpass US$ 12,846.6 Mn by the end of 2035.

3. What is driving the coronary stents market?

Key growth factors include the increasing demand for minimally invasive cardiovascular procedures and favorable reimbursement policies.

4. What will be the CAGR of the coronary stents market during 2025–2035?

The market is projected to expand at a CAGR of 5.3% from 2025 to 2035.

5. Which region is expected to hold a major share of the market?

North America is expected to account for a major share of the global coronary stents market during the forecast period.

6. Who are the prominent coronary stent manufacturers?

Key companies include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Terumo Corporation, Biosensors International Group, Elixir Medical Corp., Cook Medical Inc., OrbusNeich Medical Company Limited, Shanghai MicroPort Medical Co., Ltd., and Meril Life Sciences Pvt. Ltd., among others.

Explore Latest Research Reports by Transparency Market Research-

Sanitization Robots Market

Kidney Dialysis Equipment Market

Patient Handling Equipment Market

Multi-parameter Patient Monitoring Equipment Market

Biopsy Devices Market

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com